AI MARKET SCANNING

Alector, Inc.

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +1.77%
MAX GAP RECORD +12.02%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ALEC
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 06, 2026 Earnings Release 2026-08-06 (AFTER CLOSE)
+0.55%
May 11, 2026 Earnings Release 2026-05-11 (BEFORE OPEN)
+0.00%
Feb 25, 2026 Earnings Release 2026-02-25 (AFTER CLOSE)
-11.30%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
-2.31%
Aug 07, 2025 Earnings Release 2025-08-07 (AFTER CLOSE)
+11.64%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-0.98%
Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE)
+9.30%
Nov 06, 2024 Earnings Release 2024-11-06 (AFTER CLOSE)
+0.38%

VOLATILITY & GAP BIAS

AVG GAP MOVE 4.9%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (4)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ALEC

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease;…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗